BioMark has recently completed a very encouraging metabolome study that has implication for biomarker signature related to cancer diagnosis. The discovery is being patented.
No paperwork, no hassle. We keep things digital, easy and regular.
*Zero Spam Policy. You will need to confirm your email address to receive our news to your inbox.
Scottland’s NHS has raised concerns about the future of its NHS breast cancer screening program.
BIOMARK Announces Warrant Extension and Granting of Options Vancouver, British Columbia – (April 18th, 2024)
Form 7 Monthly Progress Report April 2024 Name of Listed Issuer: Trading Symbol: Number of
Form 7 Monthly Progress Report April 2024 Name of Listed Issuer: Trading Symbol: Number of
BIOMARK TO ADVANCE DEVELOPMENT OF CANCER TREATMENT FOR GLIOBLASTOMA The Company secured collaborative research funding
1 604 370 0779
130 3851 Shell Road
Richmond BC
Canada V6X 2W2